Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 281

Results For "IMA"

2853 News Found

Alembic announces USFDA approval for two drugs
News | May 06, 2021

Alembic announces USFDA approval for two drugs

Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution USP, 2% and 0.5% has an estimated market size of US $80 million for twelve months ending December 2020 according to IQVIA


Biosimilars performance below expectations for Biocon : ICICI Direct
Biotech | May 03, 2021

Biosimilars performance below expectations for Biocon : ICICI Direct

The progress has been encouraging with approvals and launches in the US, EU, Japan, Australia and Emerging Markets. Post Mylan Upjohn (Pfizer) merger, the scope has been extended to China as well.


India to import 450,000 vials of Remdesivir
News | May 01, 2021

India to import 450,000 vials of Remdesivir

The Government of India has started importing the vital drug Remdesivir from other countries to ease out the shortage of Remdesivir in the country


Dr. Reddy's launches Albendazole tablets in US
News | April 30, 2021

Dr. Reddy's launches Albendazole tablets in US

Dr. Reddy’s Albendazole Tablets, USP are available in 200 mg tablets in bottle count sizes of two


Indian vaccine players to garner Rs. 70,599 Cr in 2021
News | April 30, 2021

Indian vaccine players to garner Rs. 70,599 Cr in 2021

Riding COVID-19 wave, Indian vaccine industry set to be Rs. 700 billion strong


Lonza will invest CHF 200 mn to construct manufacturing complex
News | April 26, 2021

Lonza will invest CHF 200 mn to construct manufacturing complex

New manufacturing complex will occupy an overall footprint of approximately 2,000 square meter with six levels of manufacturing space


Hester launches herbal veterinary product range
News | April 26, 2021

Hester launches herbal veterinary product range

In animal health, the products will be mainly targeting mastitis and production disorders, gastrointestinal tract diseases, reproductive disorders, ectoparasites, and skin injuries


Sputnik V needs to be priced at par with Covishield & Covaxin
News | April 23, 2021

Sputnik V needs to be priced at par with Covishield & Covaxin

Market penetration of Sputnik V will depend on competitive pricing, government orders and the ability to meet soaring demand through timely supply


Caplin Steriles gets USFDA approval
News | April 23, 2021

Caplin Steriles gets USFDA approval

The injection comes in multiple formats


Vaishali Pharma initiates 30 products registration
News | April 19, 2021

Vaishali Pharma initiates 30 products registration

The company also plans to register the similar range of products in the neighbouring countries.